PMID:18232197
| Citation |
van Bronswijk, H, Dubois, EA, van Dissel, JT and Cohen, AF (2007) [New drugs; daptomycin]. Ned Tijdschr Geneeskd 151:2777-8 |
|---|---|
| Abstract |
Being a cyclic lipopeptide, daptomycin belongs to a new class of antibiotics. It acts by forming a pore in the bacterial membrane thus causing leakage of potassium and subsequent depolarization and arrest of cell function. Daptomycin has a bactericidal action on Gram-positive bacteria and is registered for the treatment of adults with complicated skin and soft tissue infections caused by Gram-positive microorganisms. There is limited experience with treatment of Staphylococcus aureus bacteraemia. Its main adverse effects include gastrointestinal symptoms, skin reactions at the site of infusion, and raised serum creatine kinase. |
| Links | |
| Keywords |
Anti-Bacterial Agents/adverse effects; Anti-Bacterial Agents/therapeutic use; Creatine Kinase/blood; Daptomycin/adverse effects; Daptomycin/therapeutic use; Exanthema/chemically induced; Gastrointestinal Diseases/chemically induced; Gram-Positive Bacteria/drug effects; Gram-Positive Bacterial Infections/drug therapy; Humans; Soft Tissue Infections/drug therapy; Treatment Outcome |
| edit table |
Significance
You can help EcoliWiki by summarizing why this paper is useful
Useful Materials and Methods
You can help Ecoliwiki by describing the useful materials (strains, plasmids, antibodies, etc) described in this paper.
Annotations
<annotationlinks/>
EcoliWiki Links
Add links to pages that link here (e.g. gene, product, method pages)
References
See Help:References for how to manage references in EcoliWiki.